Beclomethasone Dipropionate
USP/EP/BP grade glucocorticoid supplied in micronized form for MDI, DPI, and nasal spray manufacturing. Sourced for asthma prophylaxis, allergic rhinitis, and topical dermatological formulation lines.
Synthetic glucocorticoid APIs spanning topical, inhaled, injectable, and systemic formulation grades. Supplied in USP/EP/BP specification to pharmaceutical manufacturers across regulated and emerging export markets.
USP/EP/BP grade glucocorticoid supplied in micronized form for MDI, DPI, and nasal spray manufacturing. Sourced for asthma prophylaxis, allergic rhinitis, and topical dermatological formulation lines.
Long-acting glucocorticoid available as free base, dipropionate (5593-20-4), valerate (2152-44-5), and sodium phosphate (151-73-5) — USP/EP/BP grade. Supplied for topical, injectable, and antenatal corticosteroid formulation manufacturing.
Corticosteroid API for topical anti-inflammatory formulations. Supplied to specification for cream, ointment, and emollient manufacturing. CAS to be confirmed against supplier CoA — related compounds include Clobetasol Propionate (25122-41-2) and Clobetasone Butyrate (25122-57-0).
Mid-potency fluorinated corticosteroid in USP/EP/BP grade for topical, otic, and ophthalmic formulation manufacturing. Exported for dermatitis, psoriasis, eczema, and otitis externa therapeutic product lines.
Natural corticosteroid supplied as free base (50-23-7) and acetate ester (50-03-3) — USP/EP/BP grade — for oral tablet, topical cream, suppository, and injectable depot formulation manufacturing across adrenal and inflammatory indications.
Water-soluble injectable corticosteroid API in USP/EP grade for lyophilised powder-for-injection manufacturing. Sourced for emergency IV/IM protocols — anaphylaxis, acute adrenal crisis, and severe inflammatory episodes.
Synthetic glucocorticoid supplied as oral-grade base (83-43-2) and depot-injectable acetate ester (53-36-1) — USP/EP/BP grade. Exported for tablet, intra-articular suspension, and IM depot formulation lines in rheumatological and autoimmune indications.
High-potency water-soluble IV corticosteroid in USP/EP grade for lyophilised powder-for-injection manufacturing. Sourced for pulse therapy in acute spinal cord injury, transplant rejection prophylaxis, and severe asthma protocols.
High-potency non-halogenated glucocorticoid in USP/EP/BP grade for nasal spray, dry powder inhaler, and topical formulation manufacturing. Exported for allergic rhinitis, persistent asthma, and dermatological treatment product lines.
Versatile synthetic glucocorticoid supplied as oral-grade base (50-24-8) and ophthalmic-grade acetate (52-21-1) — USP/EP/BP. Exported for tablet, syrup, and ophthalmic suspension formulations across inflammatory, autoimmune, and ocular indications.
Fluorinated corticosteroid supplied as free base (124-94-7) and acetonide ester (76-25-5) — USP/EP/BP grade — for topical, intra-articular injectable, nasal spray, and inhaled formulation manufacturing across dermatological, rheumatological, and respiratory indications.